Donor-specific antibodies and antibody-mediated rejection

Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
Marc‐Antoine Béland, Isabelle Lapointe, Réal Noël, Isabelle Côté, Eric Wagner, Julie Riopel, Eva Latulippe, Olivier Désy, Stéphanie Béland, Ciara N. Magee, Isabelle Houde, Sacha A. De Serres
Transplant International 2017; 4: 502-509


Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody‐mediated injury: a retrospective study
Adil H. Gasim, Jamie S. Chua, Ron Wolterbeek, John Schmitz, Eric Weimer, Harsharan K. Singh, Volker Nickeleit
Transplant International 2017; 5: 519-532


Complement inhibition as potential new therapy for antibody‐mediated rejection
Farsad Eskandary, Markus Wahrmann, Jakob Mühlbacher, Georg A. Böhmig
Transplant International 2016; 4: 392-402


mTOR inhibitors and risk of chronic antibody‐mediated rejection after kidney transplantation: where are we now?
Philippe Grimbert, Olivier Thaunat
Transplant International 2017; 7: 647-657


Pre‐existing donor‐specific antibodies are detrimental to kidney allograft only when persistent after transplantation
Sophie Caillard, Camille Becmeur, Gabriela Gautier‐Vargas, Jerome Olagne, Clotilde Muller, Noelle Cognard, Peggy Perrin, Laura Braun, Francoise Heibel, Francois Lefebre, Veronique Renner, Christian Gachet, Bruno Moulin, Anne Parissiadis
Transplant International 2017; 1: 29-40


Clinical outcomes of ABO‐ and HLA‐incompatible kidney transplantation: a nationwide cohort study
Eun Jeong Ko, Ji Hyun Yu, Chul Woo Yang, Byung Ha Chung, the Korean Organ Transplantation Registry Study Group
Transplant International 2017; 12: 1215-1225


De novo donor‐specific anti‐HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q‐binding ability
Teresa Kauke, Cornelia Oberhauser, Viviane Lin, Michaela Coenen, Michael Fischereder, Andrea Dick, Ulf Schoenermarck, Markus Guba, Joachim Andrassy, Jens Werner, Bruno Meiser, Martin Angele, Manfred Stangl, Antje Habicht
Transplant International 2017; 4: 360-370